pyrazines has been researched along with Disease, Pulmonary in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, Y; Gemma, A; Hatake, K; Katoh, T; Kudoh, S; Kusumoto, M; Miyao, M; Miyazawa, M; Mukai, HY; Ogawa, Y; Ohyashiki, K; Sakai, F; Sugiyama, Y; Yoshizawa, K | 1 |
| Blanco Cid, N; Dacal Quintas, R; Santalla MartÃnez, M | 1 |
| Fujiwara, K; Higo, H; Inomata, T; Kameyama, N; Makimoto, G; Matsushita, M; Rai, K; Sato, K; Shibayama, T; Sunami, K; Watanabe, H | 1 |
| Hamaki, T; Hori, A; Kami, M; Kishi, Y; Kodama, Y; Komatsu, T; Matsumura, T; Narimatsu, H; Takita, M; Tanaka, Y; Yuji, K | 1 |
| Fukuda, Y; Gemma, A; Hatake, K; Katoh, T; Kudoh, S; Kusumoto, M; Mukai, H; Ohyashiki, K; Sakai, H; Sugiyama, Y | 1 |
| Bruce, JT; Devine, SM; Elder, P; Hofmeister, CC; Mastronarde, JG; Phillips, G; Tran, JM; Wood, KL | 1 |
| Wirk, B | 1 |
| Ascensao, JL; Batra, RB; Boyer, JE; Schechter, GP | 1 |
| Inaba, T; Kobayashi, Y; Shimazaki, C; Taniwaki, M | 1 |
| Fujita, M; Harada, E; Ikegame, S; Inoshima, I; Nakanishi, Y; Ouchi, H; Ye, Q | 1 |
| Altavilla, G; Arrigo, C; Naro, C; Pitini, V | 1 |
| Dan, K; Gotoh, A; Hotta, T; Ikeda, Y; Ohyashiki, K; Oshimi, K; Usui, N | 2 |
| Zhang, KJ; Zhang, YX | 1 |
| Cao, W; Demura, H; Luo, W; Naruse, M; Shi, Y; Zeng, Z; Zhu, YJ | 1 |
| Li, B | 1 |
| Boccitto, G; Sbampato, M; Sternini, N | 1 |
| Kallos, ZS; Palffy, G; Szanto, E | 1 |
| Zorini, AO | 1 |
1 review(s) available for pyrazines and Disease, Pulmonary
| Article | Year |
|---|---|
[Recent advances in experimental and clinical study on ligustrazine in treating respiratory disease].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Humans; Lung Diseases; Pyrazines | 1995 |
1 trial(s) available for pyrazines and Disease, Pulmonary
| Article | Year |
|---|---|
Dexamethasone reduces the risk of bortezomib-induced pulmonary complications in Japanese myeloma patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Asian People; Boronic Acids; Bortezomib; Dexamethasone; Female; Humans; Japan; Lung Diseases; Male; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pyrazines; Stem Cell Transplantation; Transplantation, Homologous | 2006 |
17 other study(ies) available for pyrazines and Disease, Pulmonary
| Article | Year |
|---|---|
Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterization.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Incidence; Japan; Lung Diseases; Male; Middle Aged; Multiple Myeloma; Pyrazines; Retrospective Studies; Risk | 2014 |
Bortezomib-induced lung toxicity.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Doxorubicin; Drug Substitution; Female; Humans; Lenalidomide; Lung Diseases; Multiple Myeloma; Pyrazines; Spirometry; Thalidomide | 2014 |
Diffuse parenchymal pulmonary amyloidosis showing an objective response to bortezomib-based chemotherapy.
Topics: Aged; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Boronic Acids; Bortezomib; Female; Humans; Lung Diseases; Multiple Myeloma; Pyrazines; Radiography; Treatment Outcome | 2014 |
Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cooperative Behavior; Drug Industry; Health Knowledge, Attitudes, Practice; Humans; Interdisciplinary Communication; Internet; Japan; Lung Diseases; Mass Media; Medical Staff; Multiple Myeloma; Newspapers as Topic; Patient Selection; Periodicals as Topic; Practice Guidelines as Topic; Pyrazines; Risk Assessment; Societies, Medical | 2008 |
[Lung injury associated with bortezomib therapy in Japan].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Lung Diseases; Male; Middle Aged; Multiple Myeloma; Product Surveillance, Postmarketing; Pyrazines | 2011 |
Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myeloma.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Lung Diseases; Male; Middle Aged; Multiple Myeloma; Pyrazines; Respiratory Function Tests; Risk Factors; Thalidomide | 2012 |
Bortezomib-related diffuse alveolar hemorrhage.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Hemorrhage; Humans; Lung Diseases; Male; Multiple Myeloma; Pulmonary Alveoli; Pyrazines | 2012 |
Severe pulmonary complication after bortezomib treatment for multiple myeloma.
Topics: Aged; Boronic Acids; Bortezomib; Humans; Lung Diseases; Male; Multiple Myeloma; Pyrazines | 2006 |
Doxycycline attenuated lung injury by its biological effect apart from its antimicrobial function.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Doxycycline; Drug Resistance, Bacterial; Hydroxamic Acids; Immunologic Factors; Inflammation; Lipopolysaccharides; Lung; Lung Diseases; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Neutrophils; Pulmonary Alveoli; Pyrazines; Streptococcus pneumoniae; Sulfonamides | 2007 |
Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Lung Diseases; Male; Middle Aged; Multiple Myeloma; Pleural Effusion; Pyrazines; Respiratory Insufficiency; Vasculitis | 2007 |
Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "lung injury by bortezomib" joint committee of the Japanese society of hematology and the Japanese society of clinical h
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Asian People; Boronic Acids; Bortezomib; Drug Approval; Female; Hematology; Humans; Japan; Lung Diseases; Lung Injury; Male; Multiple Myeloma; Pyrazines; Societies, Medical; Stem Cell Transplantation; Surveys and Questionnaires | 2006 |
[Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Boronic Acids; Bortezomib; Female; Hematology; Humans; Japan; Lung Diseases; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Protease Inhibitors; Pyrazines; Recurrence; Risk Factors; Societies, Medical; Stem Cell Transplantation; Surveys and Questionnaires | 2006 |
Effects of tetramethylpyrazine, a Chinese medicine, on plasma endothelin-1 levels during acute pulmonary hypoxia in anesthetized dogs.
Topics: Anesthesia, General; Animals; Blood Pressure; Dogs; Drugs, Chinese Herbal; Endothelin-1; Hemodynamics; Hypoxia; Lung Diseases; Pulmonary Alveoli; Pulmonary Circulation; Pyrazines; Vascular Resistance; Vasodilator Agents | 1998 |
[The observation of changes in plasma PGI2 and TXA2 levels and the therapeutic effect of tetramethylpyrazine in E. coli induced acute lung injury in rabbits].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Escherichia coli Infections; Lung; Lung Diseases; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Rabbits; Thromboxane B2 | 1991 |
[Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Empyema, Tuberculous; Ethambutol; Humans; Isonicotinic Acids; Kidney Function Tests; Liver Function Tests; Lung Diseases; Middle Aged; Morpholines; Pyrazines; Rifampin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1968 |
[Therapeutic results obtained in pneumonology by employing drugs administered by aerosols].
Topics: Antitubercular Agents; Humans; Lung Diseases; Neomycin; Pyrazines; Tuberculosis, Pulmonary | 1965 |
Chest diseases in Italy.
Topics: Antitubercular Agents; Bronchitis; Cycloserine; Humans; Italy; Lung Diseases; Lung Neoplasms; Pyrazines; Rifampin; Tuberculosis; Tuberculosis, Pulmonary | 1966 |